-
ATNF Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
180 Life Sciences (ATNF)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 194.92 k | 194.92 k | 194.92 k | 194.92 k | 194.92 k | 194.92 k |
Cash burn (monthly) | 317.12 k | 205.63 k | 326.36 k | 530.90 k | 74.55 k | 224.16 k |
Cash used (since last report) | 1.27 mm | 823.65 k | 1.31 mm | 2.13 mm | 298.62 k | 897.86 k |
Cash remaining | -1.08 mm | -628.73 k | -1.11 mm | -1.93 mm | -103.70 k | -702.94 k |
Runway (months of cash) | -3.4 | -3.1 | -3.4 | -3.6 | -1.4 | -3.1 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 6 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 15.85 mm |
Total shares | 4.30 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
KBL Iv Sponsor | 2.22 mm | $5.47 mm |
Bauer Ronald | 1.41 mm | $7.02 mm |
Bridgman Craig | 673.51 k | $3.36 mm |
Proequities | 0.00 | $0.00 |